102 related articles for article (PubMed ID: 19554656)
1. Lower baseline ALT cut-off values and HBV DNA levels better differentiate HBeAg- chronic hepatitis B patients from inactive chronic carriers.
Assy N; Beniashvili Z; Djibre A; Nasser G; Grosovski M; Nseir W
World J Gastroenterol; 2009 Jun; 15(24):3025-31. PubMed ID: 19554656
[TBL] [Abstract][Full Text] [Related]
2. Association of cytokines with hepatitis B virus and its antigen.
Li MH; Chen QQ; Zhang L; Lu HH; Sun FF; Zeng Z; Lu Y; Yi W; Xie Y
J Med Virol; 2020 Dec; 92(12):3426-3435. PubMed ID: 32662892
[TBL] [Abstract][Full Text] [Related]
3. Lower HBV DNA level is associated with more severe liver fibrosis in HBeAg-positive chronic hepatitis B with normal alanine transaminase.
Wang J; Zhu L; Zhang Z; Zhang S; Pan Y; Li Y; Cao F; Jiang C; Fan T; Xiong Y; Liu J; Chen Y; Yin S; Tong X; Zhu C; Liu X; Li J; Wu C; Huang R
Virol J; 2024 Jun; 21(1):127. PubMed ID: 38835029
[TBL] [Abstract][Full Text] [Related]
4. Large spontaneous HBV DNA fluctuations and potential usefulness of a single-point measurement of combined HBV DNA and quantitative HBsAg for the exclusion of HBeAg-negative chronic hepatitis B: A prospective Tunisian cohort study.
Chtourou A; Gargouri S; Elleuch E; Feki L; Smaoui F; Taktak A; Mnif K; Kassis M; Hammami A; Ben Jemaa M; Karray H
Arab J Gastroenterol; 2023 Nov; 24(4):223-229. PubMed ID: 37989673
[TBL] [Abstract][Full Text] [Related]
5. Outcome in Caucasian patients with hepatitis B e antigen negative chronic infection: A long-term observational cohort study.
Koc ÖM; Robaeys G; Topal H; Bielen R; Busschots D; Fevery J; Koek GH; Nevens F
J Med Virol; 2020 Dec; 92(12):3373-3380. PubMed ID: 32343427
[TBL] [Abstract][Full Text] [Related]
6. Serum galectin-3 levels in children with chronic hepatitis B infection and inactive hepatitis B carriers.
Uluca Ü; Şen V; Ece A; Tan İ; Karabel D; Aktar F; Karabel M; Balık H; Güneş A
Med Sci Monit; 2015 May; 21():1376-80. PubMed ID: 25968249
[TBL] [Abstract][Full Text] [Related]
7. Predictive effect of serial serum alanine aminotransferase levels on spontaneous HBeAg seroconversion in chronic genotype B and C HBV-infected children.
Wu JF; Su YR; Chen CH; Chen HL; Ni YH; Hsu HY; Wang JL; Chang MH
J Pediatr Gastroenterol Nutr; 2012 Jan; 54(1):97-100. PubMed ID: 21716132
[TBL] [Abstract][Full Text] [Related]
8. A retrospective study to determine the correlation among HBV PreS1 antigen, HBV e antigen, alanine aminotransferase, and HBV DNA.
Du S; Shen X; Sun Y; Li J; Wang J; Cai Y; Li H
Clin Res Hepatol Gastroenterol; 2024 Jun; 48(6):102369. PubMed ID: 38719147
[TBL] [Abstract][Full Text] [Related]
9. Relationship between level of hepatitis B virus DNA and liver disease: a population-based study of hepatitis B e antigen-negative persons with hepatitis B.
McMahon BJ; Bulkow L; Simons B; Zhang Y; Negus S; Homan C; Spradling P; Teshale E; Lau D; Snowball M; Livingston SE
Clin Gastroenterol Hepatol; 2014 Apr; 12(4):701-6.e1-3. PubMed ID: 24035774
[TBL] [Abstract][Full Text] [Related]
10. Importance of CHB's grey zone: analysis of patients with HBeAg negative chronic hepatitis B virus infection.
Lenartova PD; Hockickova I; Janicko M; Jarcuska P; Drazilova S; Lami F; Schreter I; Kristian P
Bratisl Lek Listy; 2024; 125(1):59-63. PubMed ID: 38041848
[TBL] [Abstract][Full Text] [Related]
11. Development of a simple score based on HBeAg and ALT for selecting patients for HBV treatment in Africa.
Shimakawa Y; Njie R; Ndow G; Vray M; Mbaye PS; Bonnard P; Sombié R; Nana J; Leroy V; Bottero J; Ingiliz P; Post G; Sanneh B; Baldeh I; Suso P; Ceesay A; Jeng A; Njai HF; Nayagam S; D'Alessandro U; Chemin I; Mendy M; Thursz M; Lemoine M
J Hepatol; 2018 Oct; 69(4):776-784. PubMed ID: 30104154
[TBL] [Abstract][Full Text] [Related]
12. DNA-guided hepatitis B treatment, viral load is essential, but not sufficient.
Bárcena Marugán R; García Garzón S
World J Gastroenterol; 2009 Jan; 15(4):423-30. PubMed ID: 19152446
[TBL] [Abstract][Full Text] [Related]
13. Determining optimal ALT cut-off values for predicting significant hepatic histological changes in patients with normal ALT in the grey zone of chronic hepatitis B virus infection.
Kang NL; Wu LY; Zheng Q; Yu XP; Hu AR; Guo Y; Li H; Ye XY; Ruan QF; Lu ZH; Wu L; Jin W; Liu YR; Pan C; Liu SS; Zhang JM; Jiang JJ; Zeng DW
Aliment Pharmacol Ther; 2024 Mar; 59(5):692-704. PubMed ID: 38178641
[TBL] [Abstract][Full Text] [Related]
14. Relationship of oxidative stress in hepatitis B infection activity with HBV DNA and fibrosis.
Duygu F; Karsen H; Aksoy N; Taskin A
Ann Lab Med; 2012 Mar; 32(2):113-8. PubMed ID: 22389877
[TBL] [Abstract][Full Text] [Related]
15. Lowering the threshold of alanine aminotransferase for enhanced identification of significant hepatic injury in chronic hepatitis B patients.
Yu HS; Jiang H; Li MK; Yang BL; Smayi A; Chen JN; Wu B; Yang YD
World J Gastroenterol; 2023 Sep; 29(35):5166-5177. PubMed ID: 37744292
[TBL] [Abstract][Full Text] [Related]
16. eALT-F: A New Non-Invasive Staging Method to Identify Medium to High-Risk Patients with HCC from Ultra-High HBV Viral Load Population - China, 2010-2023.
Zheng J; Wang X; Wang Z; Huang L; Xie Y; Jiang S; Feng B
China CDC Wkly; 2023 Dec; 5(49):1107-1114. PubMed ID: 38125914
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of Older Patients With Immunotolerant Chronic Hepatitis B Virus Infection.
Feld JJ; King WC; Ghany MG; Chang KM; Terrault N; Perrillo RP; Khalili M; Hinerman AS; Janssen H; Lok AS;
Clin Gastroenterol Hepatol; 2023 Jun; 21(6):1503-1512.e4. PubMed ID: 35843468
[TBL] [Abstract][Full Text] [Related]
18. Lifetime risk of liver-related outcomes and determinants in male inactive carriers of chronic hepatitis B.
Wu WJ; Lin CL; Liu CJ; Huang YW; Hu JT; Yu MW
J Med Virol; 2023 Oct; 95(10):e29138. PubMed ID: 37796044
[TBL] [Abstract][Full Text] [Related]
19. Inverse relationship between HBV DNA levels and liver histopathological changes in immune-tolerant CHB patients.
Huang D; Lai H; Zhu Z; Yu H; Peng J; Chen Y; Liao X; Chen J
J Viral Hepat; 2024 Jul; 31(7):363-371. PubMed ID: 38581159
[TBL] [Abstract][Full Text] [Related]
20. Can quantitative surface antigen levels and systemic immune-inflammation index be predictive as a new indicator for the initiation of treatment in chronic hepatitis b?
Koroglu M; Ayvaz MA; Bakan SB; Sirin A; Akyuz U
Eur J Gastroenterol Hepatol; 2024 Apr; 36(4):489-497. PubMed ID: 38407853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
